NJ Pot Lounges One Step Closer, DEA Sets Psychedelic Drug Production Quotas, More... (12/5/22)

Kansas's Democratic governor wants medical marijuana this coming year, the DEA announces new, higher research quotas for various psychedelics and marijuana, and more.

The DEA is upping the research quota for various psychedelics, including psilocyn, found in magic mushrooms. (Creative Commons)

New Jersey Marijuana p.ove Rules for Public Cannabis Consumption Areas. The state's Cannabis Regulatory Commission (CRC) approved rules for"public cannabis consumption areas" last Friday. That is a first step toward allowing marijuana smoking lounges to open in the state, and it is one that social justice requires, said CRC Chair Dianna Houenou. "Equitable access to cannabis means everyone who wishes to consume has some place they can do that—legally, safely, and responsibly," Houenou said. "When regulated properly, cannabis consumption areas can strengthen the industry, while giving people more choices on where they consume." Under the rules just proposed, neither alcohol nor tobacco could be sold or consumed at such facilities and food could not be sold, but people could bring their own or have it delivered to the site.

Medical Marijuana

Kansas Governor Reinforces Call for Medical Marijuana as Legislative Priority. Gov. Laura Kelly (D) last Friday reinforced the notion that she wants to make passage of a medical marijuana law a top legislative priority "This legislative session, we need to legalize medical marijuana so that Kansans with severe illnesses no longer have to suffer,"she said. "Providing this relief is long overdue, so let’s work together to get this done. Medical marijuana is one of five priorities she has identified, along with investing in mental health resources, expanding Medicaid, protecting first responders, and providing tax relief.

Psychedelics

DEA Announces How Much Marijuana, MDMA, Psilocyn, LSD, Mescaline, 5-MeO-DMT, MDA, 2-CB Can Be Produced for Research In 2023. The DEA has set production quotas for research drugs for 2023 and it is pushing those numbers up as it responds to increasing scientific and medical interest in the compounds. The agency is "committed to ensuring an adequate and uninterrupted supply of controlled substances in order to meet the estimated legitimate medical, scientific, research, and industrial needs of the U.S., for lawful export requirements, and for the establishment and maintenance of reserve stocks," the DEA said. For marijuana, the DEA recommended the production of 14,770 pounds, more than twice the amount authorized for this year, while quote numbers for psilocyn would go from the original 8,000 grams to 12,000 grams, 5-MeO-DMT from 6,000 to 11,000, MDMA from 8,200 to 12,000 grams, MDA from 200 to 12,000 grams, and 2-CB from 25 to 5,100 grams.